Product Information
- (2E)-3-[2,6-Dichloro-4-[[[4-[3-[(1S)-1-(hexyloxy)ethyl]-2-methoxyphenyl]-2-thiazolyl]amino]carbonyl]phenyl]-2-methyl-2-propenoic Acid
- S 888711
Applications Lusutrombopag is a newly discovered thrombopoietin receptor agonist used in the treatment of patients with chronic ITP.
References Katsube, T. et al.: Clin. Pharmacokinet., 55, 1423 (2016); Siegal, D. et al.: Semin. Hematol., 50, S18 (2013);
Chemical properties
Technical inquiry about: TR-L474985 Lusutrombopag
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.